WEE1 and neoplasm: WEE1 inhibitors have been reported to activate the cytosolic-DNA sensing, interferon, and JAK-STAT pathways, thereby enhancing tumor immunity through CD8+ T cell infiltration, increased cytokine and chemokine signaling, and increased PD-L1 expression [24,35].